Delivery Order SPE2DB22D9316-SPE2DB24FYP74

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $7,881.60 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Cerezyme 400 unit vials and has a completion date of June 4, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,449.60, is for the delivery of 400-unit vials of the drug Cerezyme. The contract is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the DLA to issue delivery orders to DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with DLA under the...
This is a $22,471.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Cerezyme 400 unit vials, with a performance period through November 26, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a firm fixed-price delivery order worth $7,881.60 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the delivery of 400-unit vials of the pharmaceutical product Cerezyme and has a completion date of May 20, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,449.60 firm fixed-price contract is for the delivery of Cerezyme 400 unit vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,313.60, is for the delivery of CEREZYME 400 unit vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant single-award indefinite delivery contract (IDC) with the DLA, valued at up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,136.00, is for the delivery of 400-unit vials of the biologic drug Cerezyme. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which provides a comprehensive range of pharmaceutical products to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,508.80 firm fixed-price contract is for the delivery of 400-unit vials of the drug Cerezyme through April 2024. The award is made under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB24FYN79 with DLA, which has a ceiling value of up to $4,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,449.60 firm fixed-price contract is for the supply of CEREZYME 400 unit vials, with an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP74
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $7,881.60 and covers the delivery of Cerezyme 400 unit vials, with a period of performance ending on August 12, 2024.

DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. As a prime vendor, DMS Pharmaceutical Group Inc. provides both routine and critical medications, including branded and generic prescription drugs, biologics, and medical consumables, to various Department of Defense (DoD) healthcare facilities.

This contract award does not have a set-aside designation.

Generated 10/21/24, 9:38 AM